• Phase 2 Trial to Test Exercise as Way to Improve Quality of Life in Recurring Ovarian Cancer
  • SOLO-2 Results: Maintenance Therapy with Lynparza Extends Survival in Relapsed Ovarian Cancer
  • Zejula-Avastin Combo Treating Advanced Cancer Patients in Phase 2 Trial
  • FDA Approves Lynparza Combo as First-line Maintenance Therapy for Advanced Ovarian Cancer
  • STRO-002 Continues to Show Promise in Advanced Ovarian Cancer, Early Trial Results Show
  • FDA Approves Zejula as First-line Maintenance Therapy for Advanced Ovarian Cancer
  • Industry leaders seek to advance innovative resources for rare and orphan disease communities amid COVID-19 outbreak
  • Ovarian Cancer Often More Advanced at Diagnosis in Rural Areas in US
  • Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say
  • First Advanced Cancer Patients Dosed With VT1021 in Trial’s Expansion Phase
  • Antibody-drug Conjugate XMT-1536 Shows Promise for Ovarian Cancer in Phase 1 Trial
  • Partnership to Ensure Gene-modified Cell Therapies for Ovarian Cancer Trials